GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Darya-Varia Laboratoria Tbk (ISX:DVLA) » Definitions » Debt-to-EBITDA

PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Debt-to-EBITDA : 0.00 (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is PT Darya-Varia Laboratoria Tbk Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

PT Darya-Varia Laboratoria Tbk's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was Rp435 Mil. PT Darya-Varia Laboratoria Tbk's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was Rp933 Mil. PT Darya-Varia Laboratoria Tbk's annualized EBITDA for the quarter that ended in Mar. 2024 was Rp400,596 Mil. PT Darya-Varia Laboratoria Tbk's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for PT Darya-Varia Laboratoria Tbk's Debt-to-EBITDA or its related term are showing as below:

ISX:DVLA' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0   Med: 0.01   Max: 0.09
Current: 0.01

During the past 13 years, the highest Debt-to-EBITDA Ratio of PT Darya-Varia Laboratoria Tbk was 0.09. The lowest was 0.00. And the median was 0.01.

ISX:DVLA's Debt-to-EBITDA is ranked better than
99.85% of 661 companies
in the Drug Manufacturers industry
Industry Median: 1.69 vs ISX:DVLA: 0.01

PT Darya-Varia Laboratoria Tbk Debt-to-EBITDA Historical Data

The historical data trend for PT Darya-Varia Laboratoria Tbk's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Darya-Varia Laboratoria Tbk Debt-to-EBITDA Chart

PT Darya-Varia Laboratoria Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.09 0.01 0.01

PT Darya-Varia Laboratoria Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.03 0.01 -

Competitive Comparison of PT Darya-Varia Laboratoria Tbk's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, PT Darya-Varia Laboratoria Tbk's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Darya-Varia Laboratoria Tbk's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Darya-Varia Laboratoria Tbk's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PT Darya-Varia Laboratoria Tbk's Debt-to-EBITDA falls into.



PT Darya-Varia Laboratoria Tbk Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

PT Darya-Varia Laboratoria Tbk's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(430.44 + 1043.765) / 227146.464
=0.01

PT Darya-Varia Laboratoria Tbk's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(434.778 + 933.431) / 400596.196
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


PT Darya-Varia Laboratoria Tbk  (ISX:DVLA) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


PT Darya-Varia Laboratoria Tbk Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of PT Darya-Varia Laboratoria Tbk's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Business Description

Traded in Other Exchanges
N/A
Address
Jalan. R.A. Kartini Kav. 8, 18th-19th Floor, South Quarter, Tower C, Jakarta, IDN, 12430
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, medical and dental equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics; wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory equipment, cosmetic; wholesale trade in pharmaceuticals; laboratory testing services, health support service activities, research and development, periodic inspection services, and many more activities.

PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Headlines

No Headlines